Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chimera Antigen Receptor (CAR)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06345027
What this trial is testing

Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, B-cellLeukemia, T-Cell
Baylor College of Medicine 78
Early research (Phase 1)Looking for participantsNCT07361029
What this trial is testing

CD19 Chimeric Antigen Receptor (CAR) T Cells in Adults With Relapsed/Refractory CD19 Positive Acute Lymphoblastic Leukemia

Who this might be right for
Relapsed Refractory Acute Lymphoblastic Leukemia
King Faisal Specialist Hospital & Research Center 24
Early research (Phase 1)Study completedNCT02976857
What this trial is testing

Study Evaluating Safety and Efficacy of C-CAR011 Treatment in DLBCL Subjects

Who this might be right for
Refractory Diffuse Large B-Cell Lymphoma
Shanghai AbelZeta Ltd. 15
Early research (Phase 1)Looking for participantsNCT06185751
What this trial is testing

Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 25
Early research (Phase 1)UnknownNCT05038696
What this trial is testing

ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.

Who this might be right for
Lymphoblastic Leukemia, Acute, ChildhoodLymphoblastic LeukemiaLymphoblastic Leukemia, Acute Adult+3 more
National University Hospital, Singapore 40
Early research (Phase 1)Looking for participantsNCT07055477
What this trial is testing

A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)

Who this might be right for
Relapsed and/or Refractory Mature T Cell MalignancyPeripheral T-Cell LymphomaAngioimmunoblastic T-cell Lymphoma+7 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT07744256
What this trial is testing

Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer (SCLC)Relapsed/Refractory SCLCExtensive-stage SCLC
Beijing Biotech 60
Early research (Phase 1)Looking for participantsNCT07115745
What this trial is testing

Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

Who this might be right for
Refractory Autoimmune Diseases
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 125
Early research (Phase 1)Active Not RecruitingNCT06152172
What this trial is testing

CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101

Who this might be right for
Idiopathic Inflammatory MyopathiesDiffuse Cutaneous Systemic SclerosisSLE Nephritis+1 more
David Porter 24
Testing effectiveness (Phase 2)Study completedNCT04817774
What this trial is testing

Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients

Who this might be right for
Kidney Transplant RejectionEnd Stage Renal Disease
Sangamo Therapeutics 26
Testing effectiveness (Phase 2)Looking for participantsNCT06121297
What this trial is testing

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Cabaletta Bio 28
Testing effectiveness (Phase 2)UnknownNCT04351022
What this trial is testing

CD38-targeted Chimeric Antigen Receptor T Cell (CART) in Relapesd or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Looking for participantsNCT06247501
What this trial is testing

Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation

Who this might be right for
Very High Risk Acute Lymphoblastic LeukemiaCD19 CAR-T Therapy
Seoul National University Hospital 50
Early research (Phase 1)UnknownNCT03154775
What this trial is testing

Study of Safety and Efficacy of C-CAR011 in B-NHL Patients

Who this might be right for
Refractory or Relapsed Non-Hodgkin Lymphoma
Shanghai AbelZeta Ltd. 15
Testing effectiveness (Phase 2)UnknownNCT03366324
What this trial is testing

Anti-CD19 CAR-T Therapy Combine With HSCT to Treat MRD+ B-cell Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaB Cell Lymphoma
Wuhan Sian Medical Technology Co., Ltd 20
Testing effectiveness (Phase 2)UnknownNCT02772198
What this trial is testing

T-cells Expressing Anti-CD19 CAR in Pediatric and Young Adults With B-cell Malignancies

Who this might be right for
Acute Lymphoblastic Leukemia, B-precursorNon-Hodgkin Lymphoma, B-cell
Sheba Medical Center 300
Early research (Phase 1)UnknownNCT03291444
What this trial is testing

CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS

Who this might be right for
Leukemia, Acute Lymphocytic (ALL)Leukemia, Acute Myelogenous (AML)Myelodysplastic Syndromes
Zhujiang Hospital 30
Very early researchUnknownNCT05652530
What this trial is testing

Clinical Study of the Safety and Efficacy of BCMA CAR-NK

Who this might be right for
ImmunotherapyMultiple Myeloma
Shenzhen Pregene Biopharma Co., Ltd. 19
Testing effectiveness (Phase 2)Looking for participantsNCT03765177
What this trial is testing

CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaNon-Hodgkin's LymphomaChronic Lymphocytic Leukemia
Ottawa Hospital Research Institute 60
Early research (Phase 1)Active Not RecruitingNCT05680922
What this trial is testing

DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Extensive StageLarge Cell Neuroendocrine Carcinoma of the Lung
Legend Biotech USA Inc 41
Next Page
60